Harrow Health (HROW) Misses Q4 EPS by 23c

Harrow Health (NASDAQ: HROW) reported Q4 EPS of ($0.27), $0.23 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $19.35 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• BofA maintains underperform ratings on six BDC stocks